glp-1 trump deal Eli Lilly and Novo Nordisk are lowering drug costs thanks to a new with President Trump. 💉 Some Medicare recipients could soon

Key takeaways Mounjaro (tirzepatide) is FDA approved for Type 2 diabetes but is often prescribed off-label for weight loss

Many first-time users describe a burst of energy and focus in the first week that they mistake for the appetite suppression itself

In the CONQUER Trial published in 201, researchers examined how effective Qsymia was at treating obesity

Indeed, both in rodents and humans, GLP-1 infusion increased fractional sodium excretion [20], which has been linked to the finding that sodium is more rapidly excreted following an oral versus equivalent IV sodium load in a number of experimental studies in healthy individuals, independent of factors such as atrial natriuretic peptide (ANP) and aldosterone [22]